Report Code: CMI68037

Category: Food & Beverages

Report Snapshot

CAGR: 4.5%
201Mn
2024
209Mn
2025
312Mn
2034

Source: CMI

Study Period: 2025-2034
Fastest Growing Market: North America
Largest Market: Asia Pacific

Major Players

Exclusive, in-depth market intelligence can help you increase your Revenue.

Download Sample Pdf

Reports Description

As per the current market research conducted by the CMI Team, the Global Arabinogalactan Market is expected to record a CAGR of 4.5% from 2025 to 2034. In 2025, the market size is projected to reach a valuation of USD 209 Million. By 2034, the valuation is anticipated to reach USD 312 Million.

Arabinogalactan Market Overview

Arabinogalactan, also known as galactoarabinan, larch arabinogalactan, or larch gum defined as a biopolymer composed of arabinose and galactose monosaccharides. Natural arabinogalactans are divided into two types: plant arabinogalactan and microbial arabinogalactan.

Many gums, including gum arabic and gum ghatti, contain it in large amounts. It is frequently discovered coupled to proteins, and the resulting arabinogalactan protein (AGP) serves as both an intercellular signaling molecule and a glue for sealing plant wounds.

The market is being driven by several factor including the growing demand for natural and functional ingredients, growing nutraceutical and pharmaceutical applications, growth in animal feed industry and many others. However, the limited raw material availability is one of the major challenges for the industry expansion.

  • According to the International Feed Industry Federation, today world compound feed production is estimated to be just over one billion tonnes annually. Global commercial feed manufacturing generates an estimated annual turnover of over US $400 billion.

Arabinogalactan Market Drivers

Rising Health And Wellness Trends Among Consumers Drives Market Growth

The growing demand for supplements among children and adults is the primary driver of the arabinogalactan market. Its vast range of applications, including complexation with medicinal molecules to increase bioavailability and arabinogalactan derived from larch trees, has resulted in increased demand in the pharmaceutical industry.

Furthermore, increased awareness of the need of maintaining good health, rising demand for health and dietary supplements, and the expansion of prebiotic supplements are driving demand in this market. Furthermore, the increasing use of natural and herbal products in the cosmetic industry is driving demand for this market.

Introduction Of Innovative Delivery Formats

In the market, creative delivery methods have become a main trend. Manufacturers’ active hunt for fresh approaches to give this material to consumers is changing the context of the market. One interesting development of this approach is the introduction of creative delivery techniques such drink mixes, effervescent tablets, and candy.

These models are appealing to consumers and hence convenient, which has helped them to gain popularity. These innovative goods now seamlessly feature this natural product, which is well-known for possible health benefits. Arabinogalactan gummies give consumers a delicious and handy approach to quickly add this ingredient into their daily activities.

Furthermore, effervescent tablets offer a rapid and effervescent solution that meets the needs of those seeking a sensible approach to boost immune systems or enhance gastrointestinal health. Drink mixtures also provide versatility so consumers may adjust their consumption to fit their own wellness goals. Apart from increasing consumer choices, these innovative delivery strategies are vital for quickening the growth of the market.

Arabinogalactan Market Challenge

Limited Raw Material Availability

One of the primary challenges confronting the arabinogalactan market is a lack of raw materials. Main commercial source of arabinogalactan is larch trees (Larix species), especially Western Larch (Larix occidentalis).

Unlike certain prebiotics derived from a variety of plants or microbes, the extraction of arabinogalactan is primarily dependent on forestry resources. Moreover, this is also impacted by the deforestation initiatives and strict laws. Sustainable harvesting is crucial even if it reduces huge output and raises costs.

Arabinogalactan Market Segmentation Analysis

By Type:

The western larch source segment is expected to dominate the market. Arabinogalactan, a polysaccharide derived mostly from the Western Larch tree (Larix occidentalis), is enjoying significant market expansion due to its numerous applications in industries such as food, pharmaceuticals, and cosmetics.

Besides, the mongolian larch source segment growing at a rapid rate. Innovative methods have been developed to isolate arabinogalactan from larch species, including the Mongolian Larch, resulting in increased yield and purity. The growing demand from end-use industries such as pharmaceutical and others drives the market growth.

By Application:

The food & dietary supplement segment is expected to dominate the market. The increasing consumer demand for healthy products in regards of their health, which drives demand for natural ingredients like arabinogalactan. Furthermore, a shift toward natural, plant-based substances in food and supplements is consistent with arabinogalactan’s plant-derived origin, increasing its market appeal.

Besides, the pharmaceutical segment growing at a rapid rate. The desire for natural and effective excipients in medication formulations is a key driver of arabinogalactan market expansion. Its multifunctional qualities are consistent with the industry’s shift to natural and sustainable components.

Report Scope

Feature of the Report Details
Market Size in 2025 USD 209 Million
Projected Market Size in 2034 USD 312 Million
Market Size in 2024 USD 201 Million
CAGR Growth Rate 4.5% CAGR
Base Year 2024
Forecast Period 2025-2034
Key Segment By Type, Application and Region
Report Coverage Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends
Regional Scope North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America
Buying Options Request tailored purchasing options to fulfil your requirements for research.

Arabinogalactan Market Regional Analysis

North America is projected to dominate the arabinogalactan market. The regional growth is owing to the emphasis on natural and organic products, especially in functional foods and dietary supplements. In addition, the region is home to a substantial amount of the world’s larch trees, which are the principal source of arabinogalactan, ensuring a steady supply for a variety of applications.

However, the Asia Pacific is growing at a rapid rate over the projected period. This is due to the rising awareness regarding health and increasing disposable income.

Arabinogalactan Market Recent Development

The arabinogalactan industry adopted several strategies which include product launches, acquisitions, collaboration, expansion and others. Some of the company strategies include:

  • In December 2024, Lonza, a company specializing in capsules and health ingredients, launched several products and initiatives related to arabinogalactan, including a new innovation and formulation center, a size 9 capsule for acid-sensitive ingredients, and a tailored offering for smart capsules.

The increasing product launch is the strategies that have expanded the market presence of the company in the arabinogalactan industry and gained its competitive edge.

List of the prominent players in the Arabinogalactan Market:

  • ACTYLIS
  • Ametis JSC
  • Ataman Kimya A.S.
  • Biosynth Ltd.
  • DaVinci Laboratories of Vermont
  • Dextra Laboratories Ltd.
  • ELICITYL S.A.
  • Enomark
  • Jeeva Organic
  • Lonza Group AG
  • Megazyme Ltd. by Neogen Corporation
  • Merck KgaA
  • Others

The Arabinogalactan Market is segmented as follows:

By Type

  • Western Larch Source
  • Mongolian Larch Source

By Application

  • Food & Dietary Supplement
  • Pharmaceutical
  • Others

Regional Coverage:

North America

  • U.S.
  • Canada
  • Mexico
  • Rest of North America

Europe

  • Germany
  • France
  • U.K.
  • Russia
  • Italy
  • Spain
  • Netherlands
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • New Zealand
  • Australia
  • South Korea
  • Taiwan
  • Rest of Asia Pacific

The Middle East & Africa

  • Saudi Arabia
  • UAE
  • Egypt
  • Kuwait
  • South Africa
  • Rest of the Middle East & Africa

Latin America

  • Brazil
  • Argentina
  • Rest of Latin America

Table of Contents

  • Chapter 1. Preface
    • 1.1 Report Description and Scope
    • 1.2 Research scope
    • 1.3 Research methodology
      • 1.3.1 Market Research Type
      • 1.3.2 Market research methodology
  • Chapter 2. Executive Summary
    • 2.1 Global Arabinogalactan Market, (2025 – 2034) (USD Million)
    • 2.2 Global Arabinogalactan Market : snapshot
  • Chapter 3. Global Arabinogalactan Market – Industry Analysis
    • 3.1 Arabinogalactan Market: Market Dynamics
    • 3.2 Market Drivers
      • 3.2.1 Rising pharmaceutical industry
      • 3.2.2 Growing food & beverages industry
      • 3.2.3 Growth in animal food industry
      • 3.2.4 Increasing application in cosmetics and personal care industry and plastics industry
    • 3.3 Market Restraints
    • 3.4 Market Opportunities
    • 3.5 Market Challenges
    • 3.6 Porter’s Five Forces Analysis
    • 3.7 Market Attractiveness Analysis
      • 3.7.1 Market attractiveness analysis By Type
      • 3.7.2 Market attractiveness analysis By Application
  • Chapter 4. Global Arabinogalactan Market- Competitive Landscape
    • 4.1 Company market share analysis
      • 4.1.1 Global Arabinogalactan Market: company market share, 2024
    • 4.2 Strategic development
      • 4.2.1 Acquisitions & mergers
      • 4.2.2 New Product launches
      • 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4 Research and development and Regional expansion
    • 4.3 Price trend analysis
  • Chapter 5. Global Arabinogalactan Market – Type Analysis
    • 5.1 Global Arabinogalactan Market overview: By Type
      • 5.1.1 Global Arabinogalactan Market share, By Type, 2024 and 2034
    • 5.2 Western Larch Source
      • 5.2.1 Global Arabinogalactan Market by Western Larch Source, 2025 – 2034 (USD Million)
    • 5.3 Mongolian Larch Source
      • 5.3.1 Global Arabinogalactan Market by Mongolian Larch Source, 2025 – 2034 (USD Million)
  • Chapter 6. Global Arabinogalactan Market – Application Analysis
    • 6.1 Global Arabinogalactan Market overview: By Application
      • 6.1.1 Global Arabinogalactan Market share, By Application, 2024 and 2034
    • 6.2 Food & Dietary Supplement
      • 6.2.1 Global Arabinogalactan Market by Food & Dietary Supplement, 2025 – 2034 (USD Million)
    • 6.3 Pharmaceutical
      • 6.3.1 Global Arabinogalactan Market by Pharmaceutical, 2025 – 2034 (USD Million)
    • 6.4 Others
      • 6.4.1 Global Arabinogalactan Market by Others, 2025 – 2034 (USD Million)
  • Chapter 7. Arabinogalactan’s Market – Regional Analysis
    • 7.1 Global Arabinogalactan’s Market Regional Overview
    • 7.2 Global Arabinogalactan’s Market Share, by Region, 2024 & 2034 (USD Million)
    • 7.3. North America
      • 7.3.1 North America Arabinogalactan’s Market, 2025 – 2034 (USD Million)
        • 7.3.1.1 North America Arabinogalactan’s Market, by Country, 2025 – 2034 (USD Million)
    • 7.4 North America Arabinogalactan’s Market, by Type, 2025 – 2034
      • 7.4.1 North America Arabinogalactan’s Market, by Type, 2025 – 2034 (USD Million)
    • 7.5 North America Arabinogalactan’s Market, by Application, 2025 – 2034
      • 7.5.1 North America Arabinogalactan’s Market, by Application, 2025 – 2034 (USD Million)
    • 7.6. Europe
      • 7.6.1 Europe Arabinogalactan’s Market, 2025 – 2034 (USD Million)
        • 7.6.1.1 Europe Arabinogalactan’s Market, by Country, 2025 – 2034 (USD Million)
    • 7.7 Europe Arabinogalactan’s Market, by Type, 2025 – 2034
      • 7.7.1 Europe Arabinogalactan’s Market, by Type, 2025 – 2034 (USD Million)
    • 7.8 Europe Arabinogalactan’s Market, by Application, 2025 – 2034
      • 7.8.1 Europe Arabinogalactan’s Market, by Application, 2025 – 2034 (USD Million)
    • 7.9. Asia Pacific
      • 7.9.1 Asia Pacific Arabinogalactan’s Market, 2025 – 2034 (USD Million)
        • 7.9.1.1 Asia Pacific Arabinogalactan’s Market, by Country, 2025 – 2034 (USD Million)
    • 7.10 Asia Pacific Arabinogalactan’s Market, by Type, 2025 – 2034
      • 7.10.1 Asia Pacific Arabinogalactan’s Market, by Type, 2025 – 2034 (USD Million)
    • 7.11 Asia Pacific Arabinogalactan’s Market, by Application, 2025 – 2034
      • 7.11.1 Asia Pacific Arabinogalactan’s Market, by Application, 2025 – 2034 (USD Million)
    • 7.12. Latin America
      • 7.12.1 Latin America Arabinogalactan’s Market, 2025 – 2034 (USD Million)
        • 7.12.1.1 Latin America Arabinogalactan’s Market, by Country, 2025 – 2034 (USD Million)
    • 7.13 Latin America Arabinogalactan’s Market, by Type, 2025 – 2034
      • 7.13.1 Latin America Arabinogalactan’s Market, by Type, 2025 – 2034 (USD Million)
    • 7.14 Latin America Arabinogalactan’s Market, by Application, 2025 – 2034
      • 7.14.1 Latin America Arabinogalactan’s Market, by Application, 2025 – 2034 (USD Million)
    • 7.15. The Middle-East and Africa
      • 7.15.1 The Middle-East and Africa Arabinogalactan’s Market, 2025 – 2034 (USD Million)
        • 7.15.1.1 The Middle-East and Africa Arabinogalactan’s Market, by Country, 2025 – 2034 (USD Million)
    • 7.16 The Middle-East and Africa Arabinogalactan’s Market, by Type, 2025 – 2034
      • 7.16.1 The Middle-East and Africa Arabinogalactan’s Market, by Type, 2025 – 2034 (USD Million)
    • 7.17 The Middle-East and Africa Arabinogalactan’s Market, by Application, 2025 – 2034
      • 7.17.1 The Middle-East and Africa Arabinogalactan’s Market, by Application, 2025 – 2034 (USD Million)
  • Chapter 8. Company Profiles
    • 8.1 ACTYLIS
      • 8.1.1 Overview
      • 8.1.2 Financials
      • 8.1.3 Product Portfolio
      • 8.1.4 Business Strategy
      • 8.1.5 Recent Developments
    • 8.2 Ametis JSC
      • 8.2.1 Overview
      • 8.2.2 Financials
      • 8.2.3 Product Portfolio
      • 8.2.4 Business Strategy
      • 8.2.5 Recent Developments
    • 8.3 Ataman Kimya A.S.
      • 8.3.1 Overview
      • 8.3.2 Financials
      • 8.3.3 Product Portfolio
      • 8.3.4 Business Strategy
      • 8.3.5 Recent Developments
    • 8.4 Biosynth Ltd.
      • 8.4.1 Overview
      • 8.4.2 Financials
      • 8.4.3 Product Portfolio
      • 8.4.4 Business Strategy
      • 8.4.5 Recent Developments
    • 8.5 DaVinci Laboratories of Vermont
      • 8.5.1 Overview
      • 8.5.2 Financials
      • 8.5.3 Product Portfolio
      • 8.5.4 Business Strategy
      • 8.5.5 Recent Developments
    • 8.6 Dextra Laboratories Ltd.
      • 8.6.1 Overview
      • 8.6.2 Financials
      • 8.6.3 Product Portfolio
      • 8.6.4 Business Strategy
      • 8.6.5 Recent Developments
    • 8.7 ELICITYL S.A.
      • 8.7.1 Overview
      • 8.7.2 Financials
      • 8.7.3 Product Portfolio
      • 8.7.4 Business Strategy
      • 8.7.5 Recent Developments
    • 8.8 Enomark
      • 8.8.1 Overview
      • 8.8.2 Financials
      • 8.8.3 Product Portfolio
      • 8.8.4 Business Strategy
      • 8.8.5 Recent Developments
    • 8.9 Jeeva Organic
      • 8.9.1 Overview
      • 8.9.2 Financials
      • 8.9.3 Product Portfolio
      • 8.9.4 Business Strategy
      • 8.9.5 Recent Developments
    • 8.10 Lonza Group AG
      • 8.10.1 Overview
      • 8.10.2 Financials
      • 8.10.3 Product Portfolio
      • 8.10.4 Business Strategy
      • 8.10.5 Recent Developments
    • 8.11 Megazyme Ltd. by Neogen Corporation
      • 8.11.1 Overview
      • 8.11.2 Financials
      • 8.11.3 Product Portfolio
      • 8.11.4 Business Strategy
      • 8.11.5 Recent Developments
    • 8.12 Merck KgaA
      • 8.12.1 Overview
      • 8.12.2 Financials
      • 8.12.3 Product Portfolio
      • 8.12.4 Business Strategy
      • 8.12.5 Recent Developments
    • 8.13 Others.
      • 8.13.1 Overview
      • 8.13.2 Financials
      • 8.13.3 Product Portfolio
      • 8.13.4 Business Strategy
      • 8.13.5 Recent Developments
List Of Figures

Figures No 1 to 19

List Of Tables

Tables No 1 to 52

Prominent Player

  • ACTYLIS
  • Ametis JSC
  • Ataman Kimya A.S.
  • Biosynth Ltd.
  • DaVinci Laboratories of Vermont
  • Dextra Laboratories Ltd.
  • ELICITYL S.A.
  • Enomark
  • Jeeva Organic
  • Lonza Group AG
  • Megazyme Ltd. by Neogen Corporation
  • Merck KgaA
  • Others

FAQs

The arabinogalactan market is being driven by several factors such as rising pharmaceutical industry, growing food & beverages industry, growth in animal food industry, increasing application in cosmetics and personal care industry and plastics industry and others.

The “Food & Dietary Supplement” had the largest share in the global market for Arabinogalactan.

The “Western Larch Source” category dominated the market in 2024.

The key players in the market are ACTYLIS, Ametis JSC, Ataman Kimya A.S., Biosynth Ltd., DaVinci Laboratories of Vermont, Dextra Laboratories Ltd., ELICITYL S.A., Enomark, Jeeva Organic, Lonza Group AG, Megazyme Ltd. by Neogen Corporation, Merck KgaA, Others.

“North America” is expected to dominate the market over the forecast period.

The global market is projected to grow at a CAGR of 4.5% during the forecast period, 2025-2034.

The Arabinogalactan Market size was valued at USD 209 Million in 2025.

PURCHASE OPTIONS

$

3990


$

4990


$

5990


$

2290


$

2390

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • Free 25% or 40 hours of customisation.
  • Free post-sale service assistance.
  • 15% discount on your next purchase.
  • Dedicated account Associate .
  • Permission to print the report.
  • Service guarantee available.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • Free 35% or 60 hours of customisation.
  • Free post-sale service assistance.
  • 25% discount on your next purchase.
  • Service guarantee available.
  • Personalised market brief by author.
  • Permission to print the report.
  • Report in your Language.
  • PDF, Excel and Power Point.
  • Can be accessible by unlimited users.
  • Free 40% or 80 hours of customisation.
  • Free post-sale service assistance.
  • 30% discount on your next purchase.
  • Permission to print the report.
  • Dedicated account manager.
  • Service guarantee available.
  • Report in your Language.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
  • 15% discount on your next purchase.
  • Free 20% or 10 hours of customisation.
  • In-Depth Company Profiles.
  • SWOT Analysis.
  • Identify your Competitors.
  • Recent Development Analysis.
  • Competitor Pricing Strategies.
  • Competitor Marketing Strategies.
  • Competitor Positioning and Messaging.
  • Competitor Product’s Strengths.
  • Free 20% or 10 Hours of Customisation.
  • 15% Discount on your Next Purchase.
  • Upgradable to other licenses.
  • PDF Format.
  • Permission to Print the Report.

Want to customize this report?
100% FREE CUSTOMIZATION!